Schlemm管成形术治疗成年人开角型青光眼两年随访

doi:10. 13281/j. cnki. issn.1004-4469. 2018. 01. 004

眼科

Schlemm管成形术治疗成年人开角型青光眼两年随访

刘玥陈霄雅李猛王怀洲

550004 贵阳，贵州医科大学附属医院眼科（刘玥）；100005 首都医科大学附属北京同仁医院北京同仁眼科中心眼科学与视觉科学北京市重点实验室北京市眼科研究所（刘玥、陈霄雅、李猛、王怀洲）；221002 江苏省徐州市第一人民医院眼科徐州市眼病防治研究所（陈霄雅）

收稿日期:2017-09-15 出版日期:2018-01-25 发布日期:2018-01-26
通讯作者: 王怀洲，Email：trhz_wang@163.com
基金资助:
国家自然科学基金（11571031）

Two years follow-up of adult patients with open angle glaucoma treated by canaloplasty

LIU Yue1,2, CHEN Xiao-ya2,3, LI Meng2,WANG Huai-zhou2.

1. Department of Ophthalmology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; 2. Beijing Institute of Ophthalmology; Beijing Key Laboratory of Ophthalmology & Visual Sciences; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China; 3. Department of Ophthalmology, Xuzhou First People’s Hospital, Xuzhou Eye Research Institute, Xuzhou 221002, China

Received:2017-09-15 Online:2018-01-25 Published:2018-01-26
Contact: WANG Huai-zhou, Email: trhz_wang@163.com

摘要/Abstract

摘要：

目的评估Schlemm管成形术治疗成年人开角型青光眼的有效性和安全性。设计回顾性病例系列。研究对象2011年1月至2014 年4 月北京同仁眼科中心接受Schlemm管成形术治疗的成年人开角型青光眼患者41例（50眼）。方法对上述患者行Schlemm管成形术治疗。术后3、6 个月，1、1.5、2年进行随访。对比观察青年组与中老年组、非高度近视组与高度近视组患者的眼压以及降眼压药物使用情况。以术后不使用降眼压药物，且眼压<21 mmHg为完全成功，术后需使用降眼压药物控制眼压<21 mmHg为条件成功。主要指标眼压、降眼压药物应用情况。结果术前平均眼压（24.9±8.1）mmHg，平均应用（2.7±1.2）种药物。术后3、6 个月，1、1.5、2年的平均眼压分别为（15.1±3.0）mmHg、（15.5±3.5）mmHg、（15.4±3.1）mmHg、（15.6±4.2）mmHg、（15.8±4.9）mmHg，均明显低于术前（P均=0.000）。术后2年平均应用（0.8±1.4）种药物，明显少于术前（P=0.000）。术后2年完全成功率70.3%，条件成功率92.6%。青年组与中老年组术后各时间点眼压及降眼压药物种类无统计学差异。术后1年，高度近视组眼压（14.4±3.3 mmHg）低于非高度近视组（16.2±4.5 mmHg）（P=0.035），其他时间点两组眼压及用降眼压药物无统计学差异。结论随访两年的结果表明，Schlemm管成形术对成年人开角型青光眼是一种安全有效的降眼压手术方式。（眼科， 2018, 27： 16-20）

关键词: Schlemm管成形术, 开角型青光眼

Abstract:

Objective To evaluate the efficacy and safety of canaloplasty in treating adult patients with open angle glaucoma. Design Retrospective case series. Participants 41 cases (50 eyes) of adult patients with open-angle glaucoma treated in Beijing Tongren Eye Center from January 2011 to April 2014. Method All patients were conducted with canaloplasty. The patients were followed up at 3, 6 months, 1 year, 1.5 years, and 2 years after the surgery. The intraocular pressure(IOP) and the use of IOP lowering drugs were comparative observed in youth group and middle-old age group, non-high myopia group and high myopia group. The complete success was defined as IOP was lower than 21 mmHg without any IOP lowering drugs, and conditional success was defined as IOP was lower than 21 mmHg with IOP lowering drugs. Main Outcome Measures IOP and usage status of IOP lowering drugs. Results Before the surgery, the average IOP was (24.9 ±8.1) mmHg, the average drug usage was (2.7±1.2) kinds of drugs. The mean IOP at 3, 6 months, 1 year, 1.5 years and 2 years after the surgery were (15.1±3.0) mmHg, (15.5±3.5) mmHg, (15.4±3.1) mmHg, (15.6±4.2) mmHg, (15.8±4.9) mmHg, respectively, all of which were significantly lower than those before surgery (all P=0.000). At 2 years after surgery, the average drug usage was (0.8±1.4) kinds of drugs, which was significantly less than that before surgery (P=0.000). At 2 years after surgery, the complete success rate was 70.3%, and the conditional success rate was 92.6%. There was no significant different between the youth group and middle-old age group in IOP and IOP lowering drugs at different time point after operation. One year after surgery, IOP of high myopia group (14.4±3.3 mmHg) was lower than non-high myopia group (16.2±4.5 mmHg) (P=0.035). There was no significant different between two groups in IOP and IOP lowering drugs during follow-up. Conclusion Two years follow-up showed that canaloplasty is an effective and safe way to reduce IOP in adults with open angle glaucoma. (Ophthalmol CHN, 2018, 27: 16-20)

Key words: canaloplasty, open angle glaucoma

刘玥陈霄雅李猛王怀洲. Schlemm管成形术治疗成年人开角型青光眼两年随访[J]. 眼科, doi: 10. 13281/j. cnki. issn.1004-4469. 2018. 01. 004.

LIU Yue1,2, CHEN Xiao-ya2,3, LI Meng2,WANG Huai-zhou2.. Two years follow-up of adult patients with open angle glaucoma treated by canaloplasty [J]. Ophthalmology in China, doi: 10. 13281/j. cnki. issn.1004-4469. 2018. 01. 004.

[1]	朱敬孙毅田雪莲郭娟. 选择性激光小梁成形术作为首次及辅助降眼压治疗的效果比较[J]. 眼科, 2025, 34(2): 102-107.
[2]	曾司彦侯清怡吴尧吴玲玲. 原发性开角型青光眼初诊患者的临床特征研究[J]. 眼科, 2024, 33(6): 412-416.
[3]	郑汇聪杨天予张健桑景荭辛晨王怀洲. 房角镜辅助的内路小梁切开术治疗青少年型开角型青光眼与原发性开角型青光眼12个月疗效对比[J]. 眼科, 2024, 33(4): 275-279.
[4]	刘雅聪周文宗梁四妥孙军赵华吴鑫桐王亚莉李希炜. 无黏弹剂扩张的穿透性Schlemm管成形术治疗原发性开角型青光眼的1年疗效观察[J]. 眼科, 2024, 33(1): 16-20.
[5]	狄浩浩陈旭豪张维嘉高传文钱立峰王怀洲. 内路与外路小梁切开术治疗青少年型开角型青光眼的临床对比研究[J]. 眼科, 2023, 32(6): 471-476.
[6]	张青张烨辛晨毛迎燕王宁利. 农村人群视网膜血管直径与视盘参数的关系：邯郸眼病研究[J]. 眼科, 2023, 32(3): 233-239.
[7]	辛晨. 小梁网泵调控理论及其对青光眼诊疗的启示[J]. 眼科, 2022, 31(6): 405-412.
[8]	庞睿奇彭婕婷王宁利. 原发性开角型青光眼的系统性危险因素[J]. 眼科, 2022, 31(5): 325-329.
[9]	高传文张维嘉狄浩浩秦书娟荆晶赵志玲贾飞王怀洲. 前房角镜辅助内路小梁切开术治疗原发性儿童青光眼效果观察[J]. 眼科, 2022, 31(2): 109-114.
[10]	庞睿奇王悦范肃洁曾流芝孙云晓郭奕钦李茹月曹凯王宁利. 多层级专科门诊中开角型青光眼亚型分布与人口学特征研究[J]. 眼科, 2022, 31(1): 8-13.
[11]	叶雯青古娟胡城程欢欢邓宇轩张绍丹解彦茜乐融融梁远波. 穿透性Schlemm管成形术远期效果的初步观察[J]. 眼科, 2022, 31(1): 14-19.
[12]	刘妍王怀洲康梦田. 微导管辅助的小梁切开术治疗原发开角型青光眼的远期疗效[J]. 眼科, 2021, 30(6): 435-439.
[13]	王怀洲辛晨石砚李猛王宁利. 外路微导管辅助的360度小梁切开术治疗青少年性开角型青光眼和原发性开角型青光眼的临床对照研究[J]. 眼科, 2021, 30(1): 20-24.
[14]	杨雪余晓伟范志刚. 原发性开角型青光眼的免疫机制[J]. 眼科, 2021, 30(1): 5-10.
[15]	尹鹏石砚王一玮王怀州辛晨曹凯万月王宁利. 微导管辅助的内路部分黏小管成形联合内路部分小梁切开术与内路全周小梁切开术的早期疗效对比[J]. 眼科, 2020, 29(4): 304-308.

Schlemm管成形术治疗成年人开角型青光眼两年随访

Two years follow-up of adult patients with open angle glaucoma treated by canaloplasty

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价